Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Rational Pharmacotherapy in Cardiology is Scopus-indexed (Q3, CiteScore 1.3), WoS ESCI, DOAJ. Published by Stolichnaya Izdatelskaya Kompaniya.
Checked against the index lists dated .
ISSN 1819-6446Verify ISSN ↗2225-3653Verify ISSN ↗
Publisher: Stolichnaya Izdatelskaya Kompaniya
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 207 / 278 | 25th | Q3 |
| Cardiology and Cardiovascular Medicine | 305 / 409 | 25th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q3, CiteScore 1.3.
Rational Pharmacotherapy in Cardiology is Q3 in Pharmacology (medical) (rank 207 of 278) and Q3 in Cardiology and Cardiovascular Medicine (rank 305 of 409), by CiteScore 2025.
Rational Pharmacotherapy in Cardiology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.3, which places it in quartile Q3 at the 25th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.169, quartile Q4, with an H-index of 16.
Rational Pharmacotherapy in Cardiology is published by Stolichnaya Izdatelskaya Kompaniya. Its print ISSN is 1819-6446 and its online ISSN is 2225-3653.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Rational Pharmacotherapy in Cardiology has an h-index of 29 and a 2-year mean of 0.75 citations per paper (OpenAlex). Its Scopus CiteScore is 1.3, quartile Q3. On 2-year citations it ranks #204 of 271 Scopus journals in Pharmacology (medical).
Rational Pharmacotherapy in Cardiology published 49 papers in 2025; its busiest recent year was 2020 with 148. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 74 research articles (2025–2026), authors are most often from Russia (92.6%), Vietnam (2%) and United States (2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.